SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-336045
Filing Date
2021-11-22
Accepted
2021-11-22 08:42:05
Documents
13
Period of Report
2021-11-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d268217d8k.htm   iXBRL 8-K 24730
2 EX-99.1 d268217dex991.htm EX-99.1 10488
  Complete submission text file 0001193125-21-336045.txt   158108

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crsp-20211122.xsd EX-101.SCH 2892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20211122_lab.xml EX-101.LAB 17306
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20211122_pre.xml EX-101.PRE 10929
6 EXTRACTED XBRL INSTANCE DOCUMENT d268217d8k_htm.xml XML 3263
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 211430265
SIC: 2836 Biological Products, (No Diagnostic Substances)